id stringlengths 1 5 | document_id stringclasses 98
values | passage_offset int64 0 116k | passage_text stringlengths 2 5.92k | annotation_id stringclasses 887
values | annotation_text stringlengths 1 89 | offsets listlengths 1 1 | lengths listlengths 1 1 | identifier stringlengths 0 139 ⌀ | type stringclasses 8
values | infons_json stringlengths 19 184 |
|---|---|---|---|---|---|---|---|---|---|---|
27400 | 40775613 | 27,326 | Subgroup analyses revealed a significant interaction between the relationship between HbA1c/HDL-C ratio and NAFLD in the subgroup with or without combined CVD. This finding may be closely related to the fact that patients with coronary artery disease often suffer from metabolic syndrome and disorders of lipid metabolis... | 334 | patients | [
27658
] | [
8
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
27401 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 335 | diabetic | [
28268
] | [
8
] | MESH:D003920 | Disease | {"identifier": "MESH:D003920", "type": "Disease"} |
27402 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 336 | NAFLD | [
28465
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27403 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 337 | NAFLD | [
28777
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27404 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 338 | NAFLD | [
29545
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27405 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 339 | diabetic | [
29616
] | [
8
] | MESH:D003920 | Disease | {"identifier": "MESH:D003920", "type": "Disease"} |
27406 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 340 | NAFLD | [
29774
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27407 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 341 | HDL-C | [
28449
] | [
5
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27408 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 342 | glucose | [
28971
] | [
7
] | MESH:D005947 | Chemical | {"identifier": "MESH:D005947", "type": "Chemical"} |
27409 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 343 | lipid | [
28983
] | [
5
] | MESH:D008055 | Chemical | {"identifier": "MESH:D008055", "type": "Chemical"} |
27410 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 344 | sugar | [
29040
] | [
5
] | MESH:D000073893 | Chemical | {"identifier": "MESH:D000073893", "type": "Chemical"} |
27411 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 345 | HDL-C | [
29529
] | [
5
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27412 | 40775613 | 28,207 | Although this study revealed important associations in a non-diabetic population, several limitations remain. First, because of the cross-sectional design of the study, it was not possible to determine a causal relationship between the HbA1c/HDL-C ratio and NAFLD risk. Therefore, the limitation that causality is not ye... | 346 | HDL-C | [
29846
] | [
5
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27413 | 40775613 | 29,871 | We found that in non-diabetic persons, the HbA1c/HDL-C ratio was independently and positively associated with NAFLD prevalence. Thus, the ratio may be a useful correlate of NAFLD risk. Monitoring this ratio by routine physical examination may help to identify high-risk individuals at an early stage so that lifestyle in... | 347 | diabetic | [
29892
] | [
8
] | MESH:D003920 | Disease | {"identifier": "MESH:D003920", "type": "Disease"} |
27414 | 40775613 | 29,871 | We found that in non-diabetic persons, the HbA1c/HDL-C ratio was independently and positively associated with NAFLD prevalence. Thus, the ratio may be a useful correlate of NAFLD risk. Monitoring this ratio by routine physical examination may help to identify high-risk individuals at an early stage so that lifestyle in... | 348 | NAFLD | [
29981
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27415 | 40775613 | 29,871 | We found that in non-diabetic persons, the HbA1c/HDL-C ratio was independently and positively associated with NAFLD prevalence. Thus, the ratio may be a useful correlate of NAFLD risk. Monitoring this ratio by routine physical examination may help to identify high-risk individuals at an early stage so that lifestyle in... | 349 | NAFLD | [
30044
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27416 | 40775613 | 29,871 | We found that in non-diabetic persons, the HbA1c/HDL-C ratio was independently and positively associated with NAFLD prevalence. Thus, the ratio may be a useful correlate of NAFLD risk. Monitoring this ratio by routine physical examination may help to identify high-risk individuals at an early stage so that lifestyle in... | 350 | NAFLD | [
30276
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27417 | 40775613 | 29,871 | We found that in non-diabetic persons, the HbA1c/HDL-C ratio was independently and positively associated with NAFLD prevalence. Thus, the ratio may be a useful correlate of NAFLD risk. Monitoring this ratio by routine physical examination may help to identify high-risk individuals at an early stage so that lifestyle in... | 351 | HDL-C | [
29920
] | [
5
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27418 | 40775613 | 30,413 | HDL-C | 352 | HDL-C | [
30413
] | [
5
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27419 | 40775613 | 30,456 | NAFLD | 353 | NAFLD | [
30456
] | [
5
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27420 | 40775613 | 30,462 | Nonalcoholic fatty liver disease | 354 | Nonalcoholic fatty liver disease | [
30462
] | [
32
] | MESH:D065626 | Disease | {"identifier": "MESH:D065626", "type": "Disease"} |
27421 | 40775613 | 30,498 | Triglycerides | 355 | Triglycerides | [
30498
] | [
13
] | MESH:D014280 | Chemical | {"identifier": "MESH:D014280", "type": "Chemical"} |
27422 | 40775613 | 30,515 | Total cholesterol | 356 | Total | [
30515
] | [
5
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27423 | 40775613 | 30,515 | Total cholesterol | 357 | cholesterol | [
30521
] | [
11
] | MESH:D002784 | Chemical | {"identifier": "MESH:D002784", "type": "Chemical"} |
27424 | 40775613 | 30,575 | PIR | 358 | PIR | [
30575
] | [
3
] | - | Chemical | {"identifier": "-", "type": "Chemical"} |
27425 | 40775613 | 30,607 | Alanine aminotransferase | 359 | Alanine aminotransferase | [
30607
] | [
24
] | 2875 | Gene | {"identifier": "2875", "type": "Gene"} |
27426 | 40775613 | 30,632 | AST | 360 | AST | [
30632
] | [
3
] | 26503 | Gene | {"identifier": "26503", "type": "Gene"} |
27427 | 40775613 | 30,663 | GGT | 361 | GGT | [
30663
] | [
3
] | 653590 | Gene | {"identifier": "653590", "type": "Gene"} |
27428 | 40775613 | 30,667 | Gamma-glutamyltranspeptidase | 362 | Gamma-glutamyltranspeptidase | [
30667
] | [
28
] | 102724197 | Gene | {"identifier": "102724197", "type": "Gene"} |
27429 | 40775613 | 30,716 | CVD | 363 | CVD | [
30716
] | [
3
] | Disease | {"type": "Disease"} | |
27430 | 40775613 | 30,720 | Coronary heart disease | 364 | Coronary heart disease | [
30720
] | [
22
] | MESH:D003327 | Disease | {"identifier": "MESH:D003327", "type": "Disease"} |
27431 | 40775613 | 30,743 | CAP | 365 | CAP | [
30743
] | [
3
] | MESH:C538265 | Disease | {"identifier": "MESH:C538265", "type": "Disease"} |
27432 | 40775613 | 30,780 | LSM | 366 | LSM | [
30780
] | [
3
] | MESH:D017093 | Disease | {"identifier": "MESH:D017093", "type": "Disease"} |
27433 | 40775613 | 30,784 | Liver stiffness measurement | 367 | Liver stiffness | [
30784
] | [
15
] | MESH:D017093 | Disease | {"identifier": "MESH:D017093", "type": "Disease"} |
27434 | 40775613 | 31,476 | The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki and were approved by the NCHS Ethics Review Board. The patients/participants provided their written informed consent to participate in this study. | 368 | human | [
31513
] | [
5
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
27435 | 40775613 | 31,476 | The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki and were approved by the NCHS Ethics Review Board. The patients/participants provided their written informed consent to participate in this study. | 369 | participants | [
31519
] | [
12
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
27436 | 40775613 | 31,476 | The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki and were approved by the NCHS Ethics Review Board. The patients/participants provided their written informed consent to participate in this study. | 370 | human | [
31533
] | [
5
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
27437 | 40775613 | 31,476 | The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki and were approved by the NCHS Ethics Review Board. The patients/participants provided their written informed consent to participate in this study. | 371 | human | [
31553
] | [
5
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
27438 | 40775613 | 31,476 | The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki and were approved by the NCHS Ethics Review Board. The patients/participants provided their written informed consent to participate in this study. | 372 | patients | [
31681
] | [
8
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
27439 | 40775613 | 31,476 | The portions of this study involving human participants, human materials, or human data were conducted in accordance with the Declaration of Helsinki and were approved by the NCHS Ethics Review Board. The patients/participants provided their written informed consent to participate in this study. | 373 | participants | [
31690
] | [
12
] | 9606 | Species | {"identifier": "9606", "type": "Species"} |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.